In October 2015, the World Health Organization reported that the Millennium Development Goal (MDG) to halt and reverse TB incidence (MDG 6c) was achieved on a worldwide basis, in each of WHO’s six regions and in 16 of the WHO’s 22 high-burden countries. While this progress is commendable, recent evidence suggests the trend may be reversing.
Since entering the New Funding Model (NFM) as an early applicant in 2013, Zimbabwe has been a unique case for Global Fund investments. The country submitted a single HIV concept note in April 2013 (before integrated HIV/TB concept notes were encouraged), was granted $311.2 million, and began implementation in January 2014.
The EECA region saw the launching of an initiative improving the effectiveness of HIV treatment. The initiative addresses the high HIV incidence, the maintaining of the HIV care cascade, which remains a problem in most EECA states. According to WHO data from 2014, 55% of HIV-positives are aware of their status, while only 71% of those who know their status are officially registered.
In a joint statement, the communities and civil society delegations to the Global Fund Board commended the pledges from donor governments, implementing countries, the private sector, and civil society partners for the Fund’s Fifth Replenishment.
Among the grants approved by the Board in August (see GFO article) were four regional programs which received $25 million. The Board was acting on recommendations of the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC). This article provides a summary of the some of the comments made by the GAC concerning the regional programs.
As reported in GFO #293, the Board has awarded Tanzania’s shortened HIV grant an extension of $109 million to allow it to continue providing essential HIV services through to the end of 2017. The original grant, totaling $277.5 million had an end date of 31 December 2016.
The Board has approved $77 million to extend Mozambique shortened HIV grant (MOZ-H-MOH). The additional funds will allow Mozambique to continue providing services through to the end of 2017. The Board was acting on the recommendations of Technical Review Panel and the Grant Approvals Committee.